POTENTIATION OF THE "DOPA" EFFECT IN PARKINSONISM BY A DIRECT GABA RECEPTOR AGONIST
- 10 March 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 323 (8376), 559
- https://doi.org/10.1016/s0140-6736(84)90947-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Menstrual Abnormalities, Nutritional Patterns, and Body Composition in Female Classical Ballet DancersThe Physician and Sportsmedicine, 1983
- Is athletic amenorrhea specific to runners?American Journal of Obstetrics and Gynecology, 1982
- COMPLICATED RESPONSE FLUCTUATIONS IN PARKINSON'S DISEASE: RESPONSE TO INTRAVENOUS INFUSION OF LEVODOPAThe Lancet, 1982
- Study of serotonin in neuropsychiatric disorders.Journal of Histochemistry & Cytochemistry, 1982
- Reproductive system function in women cross-country runnersMedicine & Science in Sports & Exercise, 1981
- Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implicationsMolecular and Cellular Biochemistry, 1981
- Supersensitivity of substantia nigra pars reticulata neurons to gabaergic drugs after striatal lesionsLife Sciences, 1981
- SECONDARY AMENORRHŒA IN ATHLETESThe Lancet, 1978
- SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASEThe Lancet, 1977
- “On‐off” phenomenon with levodopa therapy in parkinsonismNeurology, 1974